{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:38:00Z","timestamp":1789641480796,"version":"4.0.0"},"reference-count":21,"publisher":"Zhejiang University Press","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1631\/jzus.b1300307","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T17:10:41Z","timestamp":1402420241000},"page":"533-539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro"],"prefix":"10.1631","volume":"15","author":[{"given":"Jing-yao","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui-jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-he","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2014,6,1]]},"reference":[{"issue":"1","key":"3655_CR1","first-page":"46","volume":"8","author":"W Abramovits","year":"2010","unstructured":"Abramovits, W., Gupta, A.K., 2010. Veregen (sinecatechins ointment) 15%. Skinmed, 8(1):46\u201349.","journal-title":"Skinmed"},{"issue":"6","key":"3655_CR2","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/hep.24610","volume":"54","author":"S Ciesek","year":"2011","unstructured":"Ciesek, S., von Hahn, T., Colpitts, C.C., et al., 2011. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology, 54(6):1947\u20131955. [doi:10. 1002\/hep.24610]","journal-title":"Hepatology"},{"issue":"10","key":"3655_CR3","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1248\/bpb.33.1728","volume":"33","author":"XY Cui","year":"2010","unstructured":"Cui, X.Y., Inagaki, Y., Xu, H.L., et al., 2010. Anti-hepatitis B virus activities of cinobufacini and its active components bualin and cinobufagin in HepG2. 2.15 cells. Biol. Pharm. Bull., 33(10):1728\u20131732. [doi:10.1248\/bpb.33.1728]","journal-title":"2.15 cells. Biol. Pharm. Bull."},{"issue":"6","key":"3655_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/00002030-200204120-00020","volume":"16","author":"G Fassina","year":"2002","unstructured":"Fassina, G., Buffa, A., Benelli, R., et al., 2002. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS, 16(6):939\u2013941. [doi:10.1097\/00002030-200204120-00020]","journal-title":"AIDS"},{"issue":"3","key":"3655_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1386-6532(02)00107-5","volume":"25","author":"J Feld","year":"2002","unstructured":"Feld, J., Locarnini, S., 2002. Antiviral therapy for hepatitis B virus infections: new targets and technical challenges. J. Clin. Virol., 25(3):267\u2013283. [doi:10.1016\/S1386-6532(02) 00107-5]","journal-title":"J. Clin. Virol."},{"issue":"10","key":"3655_CR6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1248\/bpb.22.1122","volume":"22","author":"S Harada","year":"1999","unstructured":"Harada, S., Haneda, E., Maekawa, T., et al., 1999. Casein kinase II (CK-II)-mediated stimulation of HIV-1 reverse transcriptase activity and characterization of selective inhibitors in vitro. Biol. Pharm. Bull., 22(10):1122\u20131126. [doi:10.1248\/bpb.22.1122]","journal-title":"Biol. Pharm. Bull."},{"issue":"31","key":"3655_CR7","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1038\/sj.onc.1206708","volume":"22","author":"K Hastak","year":"2003","unstructured":"Hastak, K., Gupta, S., Ahmad, N., et al., 2003. Role of p53 and NF-\u03baB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene, 22(31):4851\u20134859. [doi:10.1038\/ sj.onc.1206708]","journal-title":"Oncogene"},{"issue":"6","key":"3655_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.jaci.2004.02.044","volume":"113","author":"K Kawai","year":"2004","unstructured":"Kawai, K., Tsuno, N.H., Kitayama, J., et al., 2004. Epigallocatechin gallate attenuates adhesion and migration of CD8+ T cells by binding to CD11b. J. Allergy Clin. Immunol., 113(6):1211\u20131217. [doi:10.1016\/j.jaci.2004.02.044]","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"3655_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jaci.2004.10.005","volume":"115","author":"K Kawai","year":"2005","unstructured":"Kawai, K., Tsuno, N.H., Kitayama, J., et al., 2005. Epigallocatechin gallate induces apoptosis of monocytes. J. Allergy Clin. Immunol., 115(1):186\u2013191. [doi:10.1016\/j.jaci. 2004.10.005]","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"3655_CR10","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1158\/0008-5472.CAN-05-3636","volume":"66","author":"N Khan","year":"2006","unstructured":"Khan, N., Afaq, F., Saleem, M., et al., 2006. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res., 66(5):2500\u20132555. [doi:10.1158\/0008-5472.CAN-05-3636]","journal-title":"Cancer Res."},{"key":"3655_CR11","unstructured":"Nakane, H., Ono, K., 1989. Differential inhibition of HIV-reverse transcriptase and various DNA and RNA polymerases by some catechin derivatives. Nucl. Acids Symp. Ser., (21):115-116."},{"issue":"11","key":"3655_CR12","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/ptr.3155","volume":"24","author":"R Pang","year":"2010","unstructured":"Pang, R., Tao, J.Y., Zhang, S.L., et al., 2010. In vitro antiviral activity of lutein against hepatitis B virus. Phytother. Res., 24(11):1627\u20131630. [doi:10.1002\/ptr.3155]","journal-title":"Phytother. Res."},{"issue":"970","key":"3655_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/pgmj.2006.047431","volume":"82","author":"NH Park","year":"2006","unstructured":"Park, N.H., Song, I.H., Chung, Y.H., 2006. Chronic hepatitis B in hepatocarcinogenesis. J. Postgrad. Med. J., 82(970):507\u2013515. [doi:10.1136\/pgmj.2006.047431]","journal-title":"J. Postgrad. Med. J."},{"issue":"S1","key":"3655_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-2005-915647","volume":"25","author":"RP Perrillo","year":"2005","unstructured":"Perrillo, R.P., 2005. Current treatment of chronic hepatitis B: benefits and limitations. Semin. Liver Dis., 25(S1):20\u201328. [doi:10.1055\/s-2005-915647]","journal-title":"Semin. Liver Dis."},{"issue":"8","key":"3655_CR15","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1002\/art.10443","volume":"46","author":"R Singh","year":"2002","unstructured":"Singh, R., Ahmed, S., Islam, N., et al., 2002. Epigallocatechin-3-gallate inhibits interleukin-1\u03b2-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum., 46(8):2079\u20132086. [doi:10. 1002\/art.10443]","journal-title":"Arthritis Rheum."},{"issue":"5","key":"3655_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/bph.12009","volume":"168","author":"J Steinmann","year":"2013","unstructured":"Steinmann, J., Buer, J., Pietschmann, T., et al., 2013. Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Brit. J. Pharmacol., 168(5):1059\u20131073. [doi:10.1111\/bph.12009]","journal-title":"Brit. J. Pharmacol."},{"issue":"4","key":"3655_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.dld.2006.11.004","volume":"39","author":"F Stickel","year":"2007","unstructured":"Stickel, F., Schuppan, D., 2007. Herbal medicine in the treatment of liver diseases. Dig. Liver Dis., 39(4):293\u2013304. [doi:10.1016\/j.dld.2006.11.004]","journal-title":"Dig. Liver Dis."},{"issue":"3","key":"3655_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.antiviral.2007.11.011","volume":"78","author":"J Xu","year":"2008","unstructured":"Xu, J., Wang, J., Deng, F., et al., 2008. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. Antivir. Res., 78(3):242\u2013249. [doi:10. 1016\/j.antiviral.2007.11.011]","journal-title":"Antivir. Res."},{"issue":"1","key":"3655_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0166-3542(01)00189-9","volume":"53","author":"K Yamaguchi","year":"2002","unstructured":"Yamaguchi, K., Honda, M., Ikigai, H., et al., 2002. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antivir. Res., 53(1):19\u201334. [doi:10.1016\/S0166-3542(01)00189-9]","journal-title":"Antivir. Res."},{"issue":"2","key":"3655_CR20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/hep.23384","volume":"51","author":"L Zhang","year":"2010","unstructured":"Zhang, L., Wang, G., Hou, W., et al., 2010. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review. Hepatology, 51(2):690\u2013698. [doi:10.1002\/hep.23384]","journal-title":"Hepatology"},{"issue":"12","key":"3655_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jnutbio.2006.12.016","volume":"18","author":"MC Zhen","year":"2007","unstructured":"Zhen, M.C., Wang, Q., Huang, X.H., et al., 2007. Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis. J. Nutr. Biochem., 18(12):795\u2013805. [doi:10.1016\/j.jnutbio.2006.12.016]","journal-title":"J. Nutr. Biochem."}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1300307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1631\/jzus.B1300307\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1300307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1300307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T05:00:11Z","timestamp":1559624411000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1631\/jzus.B1300307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["3655"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b1300307","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}